Quarterly report pursuant to Section 13 or 15(d)

Stockholders' Equity (Details Narrative)

v3.21.1
Stockholders' Equity (Details Narrative)
3 Months Ended
Feb. 11, 2021
USD ($)
$ / shares
shares
Mar. 31, 2021
USD ($)
Mar. 31, 2020
USD ($)
Nov. 30, 2020
USD ($)
$ / shares
shares
Proceeds from issuance of common stock | $ $ 41,400,000      
Cash offering costs | $ $ 3,300,000 $ 3,270,000 $ 80,000  
Number of shares issued | shares 5,914,284      
Share price per share | $ / shares $ 7.00      
Warrants to purchase shares | shares 2,957,142      
Warrants exercise price | $ / shares $ 7.00      
Warrant expire date Feb. 11, 2026      
Warrants grant date fair value | $ / shares $ 4.84      
Warrants aggregate grant date fair value | $ $ 14,312,567      
Warrants stock price | $ / shares $ 7.53      
Warrants contractual term 2 years 6 months      
Recognized share-based compensation | $   129,164 $ 130,890  
Unrecognized stock-based compensation expense | $   $ 1,000,000    
Weighted average remaining vesting period   1 year 9 months 18 days    
Maximum [Member]        
Warrants stock price | $ / shares       $ 8.91
Warrants contractual term       2 years 6 months
Minimum [Member]        
Warrants stock price | $ / shares       $ 9.31
Warrants contractual term       3 years 6 months
Preferred Share Exchange [Member]        
Warrants to purchase shares | shares       20,000
Board of Directors [Member]        
Warrants to purchase shares | shares       6,400
Warrants aggregate grant date fair value | $       $ 211,976
Risk Free Interest Rate [Member]        
Warrants, measurement input 0.11     0.47
Volatility [Member]        
Warrants, measurement input 113.1     113
Dividends [Member]        
Warrants, measurement input 0     0